Regulatory Update #261

10 November 2017

Opportunities and challenges for regulatory science, technology and innovation

Our recent Chief Scientist blog summarises how changes in science, technology and innovation impact APVMA regulation.

These issues were discussed at the APVMA industry sessions in September. Topics included nanotechnology, biotechnology, bio-pesticides, stem cell therapies and gene therapies. By engaging with industry and stakeholders to understand emerging sciences, our work can evolve in unison with developments in the agvet industry.

Read more

APVMA participation at international steering committee in Tokyo

Next week our interim CEO, Dr Chris Parker will attend the
35th steering committee of VICH – International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products in Tokyo, Japan.

VICH is a trilateral program between the EU, Japan and the USA, with a number of countries—including Australia—being observer members. We will be attending the meetings as an observer member, contributing to discussions and promoting coordination between national regulatory agencies. VICH guidance is used as a reference for our regulatory work and we have adopted several VICH guidelines where they are suitable to Australian conditions.

Read more

APVMA archive content to be decommissioned in December 2017

A recent review found that our archive site is not frequently visited and that the majority of visits to the archive are made only to view application summaries. As a result of this data—and to ensure that our content is current and easy to access—we intend to decommission the APVMA archive site in December 2017. As an exception, application summaries will remain accessible online.

We invite you to provide feedback and outline any concerns you might have with our plans. If you would like us to consider specific content that you believe is of value, please submit your feedback with the URL address of the content and a rationale as to why that content should be kept. Appropriate content will be migrated to the current APVMA website. All content that is found to be out-dated or inconsistent with current information will be removed.

Our intention to decommission the archive site is part of the ongoing commitment to improve user experience through enhancing the information and functionality of our website.

Please email your feedback to by Friday 17 November 2017.

Procymidone Human Health Risk Assessment report published

The Reconsideration of Procymidone: Human health risk assessment (including Toxicology and Work Health Safety) is now available on the APVMA website.

The report concludes that there is no objection on human health grounds to the continued registration of existing procymidone products in Australia and identified some additions and amendments to the existing First Aid Instructions and Safety Directions (FAISD).

Improving our business and simplifying registration for clients

The APVMA is delivering a range of projects funded by the Department of Agriculture and Water Resources, and the Australian Government’s Agricultural Competitiveness White Paper to improve our business and simplify the registration process for our clients and stakeholders.

View our progress on these projects by visiting the information on our website.

Reminder—open for public consultation

We regularly seek input throughout chemical registration and review processes, and other operational and regulatory processes. We are currently seeking input on the following open consultations:

Contact us

Australian Pesticides and Veterinary Medicines Authority
PO Box 6182
Kingston, Australian Capital Territory 2604

Add us to your address book

To protect your privacy, please do not include contact information in your feedback. If you would like a response, please contact us.